Supreme Court hears oral argument in Myriad Genetics *

USA - April 17 2013
The United States Supreme Court, on April 15, heard oral argument in Association for Molecular Pathology v. Myriad Genetics, No. 12-398. This case is…

Co-authors: Dana Lau, Ph.D., Robert H. Fischer.

Association for Molecular Pathology et al. v. USPTO and Myriad Genetics: the Federal Circuit again affirms the patentability of isolated human genes *

USA - August 17 2012
In a widely awaited decision, a panel for the Federal Circuit in Association for Molecular Pathology et al. v. USPTO and Myriad Genetics has held that (1) composition claims to isolated DNA molecules are patent-eligible subject matter, (2) Myriad’s method claims containing “comparing” and “analyzing” DNA sequence steps are patent-ineligible subject matter, but (3) Myriad’s method-of-screening claim involving transformed cells is patent-eligible subject matter.

Co-authors: Dana Lau, Ph.D., Robert H. Fischer.

Ass’n for Molecular Pathology v. USPTO, no. 2010-1406 (July 29, 2011) (the Myriad Genetics case) *

USA - July 29 2011
The Federal Circuit today issued a key biotechnology opinion, holding that isolated human DNA sequences are patentable subject matter under 35 U.S.C. § 101.

Co-authors: Robert H. Fischer.